ATM and thymus lymphoma: Mice genetically deficient in Atm present early onset of thymic lymphomas [3]–[5], and enhanced susceptibility to a variety of experimentally induced cancers, such as, mammary tumors, skin tumors, B-cell lymphomas, intestinal tumors, and others [6]–[13].